Chemistry:CUMYL-CH-MEGACLONE

CUMYL-CH-MEGACLONE
Legal status
Legal status	CA: Schedule II ; DE: NpSG (Industrial and scientific use only) ; UK: Under Psychoactive Substances Act ;
Identifiers
	IUPAC name 2,5-Dihydro-2-(1-methyl-1-phenylethyl)-5-(cyclohexylmethyl)-1H-pyrido[4,3-b]indol-1-one;
PubChem CID	155884822;
ChemSpider	97091815;
UNII	9QA3AM2G3T;
Chemical and physical data
Formula	C27H30N2O
Molar mass	398.54 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C)(C1=CC=CC=C1)N2C=CC3=C(C2=O)C4=CC=CC=C4N3CC5CCCCC5;
	InChI InChI=1S/C27H30N2O/c1-27(2,21-13-7-4-8-14-21)29-18-17-24-25(26(29)30)22-15-9-10-16-23(22)28(24)19-20-11-5-3-6-12-20/h4,7-10,13-18,20H,3,5-6,11-12,19H2,1-2H3; Key:CGHCGYCTOLWAPL-UHFFFAOYSA-N;

Short description: Chemical compound

CUMYL-CH-MEGACLONE (CUMYL-CHMGACLONE, SGT-270) is a gamma-carboline based synthetic cannabinoid receptor agonist that has been sold as a designer drug, first being identified in Hungary in December 2018.^[1]^[2]^[3]

References

↑ "Adding more "spice" to the pot: A review of the chemistry and pharmacology of newly emerging heterocyclic synthetic cannabinoid receptor agonists". Drug Testing and Analysis 12 (3): 297–315. March 2020. doi:10.1002/dta.2752. PMID 31854124.
↑ "The Novel Psychoactive Substance Cumyl-CH-MEGACLONE: Human Phase-I Metabolism, Basic Pharmacological Characterization, and Comparison to Other Synthetic Cannabinoid Receptor Agonists with a γ-Carboline-1-one Core.". Journal of Analytical Toxicology 45 (3): 277–290. June 2020. doi:10.1093/jat/bkaa065. PMID 32514544.
↑ "Clinical symptoms and blood concentration of new psychoactive substances (NPS) in intoxicated and hospitalized patients in the Budapest region of Hungary (2018-19)". Clinical Toxicology (Philadelphia, Pa.) 60 (1): 18–24. June 2021. doi:10.1080/15563650.2021.1928162. PMID 34080493.

0.00

(0 votes)

Original source: https://en.wikipedia.org/wiki/CUMYL-CH-MEGACLONE. Read more

[pmid31854124-1] "Adding more "spice" to the pot: A review of the chemistry and pharmacology of newly emerging heterocyclic synthetic cannabinoid receptor agonists". Drug Testing and Analysis 12 (3): 297–315. March 2020. doi:10.1002/dta.2752. PMID 31854124.

[2] "The Novel Psychoactive Substance Cumyl-CH-MEGACLONE: Human Phase-I Metabolism, Basic Pharmacological Characterization, and Comparison to Other Synthetic Cannabinoid Receptor Agonists with a γ-Carboline-1-one Core.". Journal of Analytical Toxicology 45 (3): 277–290. June 2020. doi:10.1093/jat/bkaa065. PMID 32514544.

[pmid34080493-3] "Clinical symptoms and blood concentration of new psychoactive substances (NPS) in intoxicated and hospitalized patients in the Budapest region of Hungary (2018-19)". Clinical Toxicology (Philadelphia, Pa.) 60 (1): 18–24. June 2021. doi:10.1080/15563650.2021.1928162. PMID 34080493.

[1]

[2]

[3]

Anonymous

Search

Chemistry:CUMYL-CH-MEGACLONE

Namespaces

More

Page actions

See also

References

Navigation

Navigation

Help

Translate

Wiki tools

Wiki tools

Legal status

Legal status	CA: Schedule II DE: NpSG (Industrial and scientific use only) UK: Under Psychoactive Substances Act
Identifiers
IUPAC name 2,5-Dihydro-2-(1-methyl-1-phenylethyl)-5-(cyclohexylmethyl)-1H-pyrido[4,3-b]indol-1-one
PubChem CID	155884822
ChemSpider	97091815
UNII	9QA3AM2G3T
Chemical and physical data
Formula	C₂₇H₃₀N₂O
Molar mass	398.54 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES CC(C)(C1=CC=CC=C1)N2C=CC3=C(C2=O)C4=CC=CC=C4N3CC5CCCCC5
InChI InChI=1S/C27H30N2O/c1-27(2,21-13-7-4-8-14-21)29-18-17-24-25(26(29)30)22-15-9-10-16-23(22)28(24)19-20-11-5-3-6-12-20/h4,7-10,13-18,20H,3,5-6,11-12,19H2,1-2H3 Key:CGHCGYCTOLWAPL-UHFFFAOYSA-N

Anonymous

Search

Chemistry:CUMYL-CH-MEGACLONE

See also

References

Navigation

Wiki tools

Page tools

Other projects

Categories